Voltaren and Claforan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Voltaren (diclofenac sodium) and Claforan (cefotaxime sodium). Common drug interactions include neutropenia among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Voltaren and Claforan. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.

What is Claforan?

Claforan has active ingredients of cefotaxime sodium. eHealthMe is studying from 2,527 Claforan users. Check the latest studies of Claforan.



On Jul, 08, 2026

17 people who take Voltaren and Claforan together, and have interactions are studied.

Voltaren and Claforan drug interactions.

What are the common drug interactions of Voltaren and Claforan, by gender? *:

female:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Pyrexia (fever)
  3. Surgery
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Blood creatinine increased
  6. Candida sepsis (candida in blood stream)
  7. Catheter related infection
  8. Cerebral infarction (less blood supply to brain resulting tissue damage)
  9. Conjunctivitis (pink eye)
  10. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)

male:

  1. Pyrexia (fever)
  2. Erythema (redness of the skin)
  3. C-reactive protein increased
  4. Rash
  5. Brain natriuretic peptide increased
  6. Cardiac failure congestive
  7. Conjunctival hyperaemia (congestion of conjunctival vessels)
  8. Erythema multiforme (a type of hypersensitivity reaction)
  9. Inflammation
  10. White blood cell count increased

What are the common drug interactions of Voltaren and Claforan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Atrioventricular block (heart block)
  2. Bacterial infection
  3. Blood pressure decreased
  4. Heart rate decreased
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Proteinuria (presence of protein in the urine)
  7. Pyrexia (fever)
  8. Sick sinus syndrome (a collection of heart rhythm disorders)
  9. Blood lactate dehydrogenase increased
  10. Brain natriuretic peptide increased

20-29:

n/a

30-39:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Dyspnoea (difficult or laboured respiration)
  3. Haemophilus infection (bacterial infection by haemophilus influenzae)
  4. Headache (pain in head)
  5. Infection
  6. Influenza like illness
  7. Pyrexia (fever)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Sore throat (pain or irritation of the throat)
  10. Tooth abscess (pus formation in tooth)

40-49:

  1. Alanine aminotransferase increased
  2. Blood lactate dehydrogenase increased
  3. C-reactive protein increased
  4. Enanthema (rash formed inside the body)
  5. Erythema (redness of the skin)
  6. Gamma-glutamyltransferase increased
  7. Oral mucosal erythema (redness of the mucous membrane of mouth)
  8. Pruritus (severe itching of the skin)
  9. Rash
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

  1. Cerebral infarction (less blood supply to brain resulting tissue damage)
  2. Nephrogenic diabetes insipidus (a disorder in which a defect in the small tubes (tubules) in the kidneys causes a person to pass a large amount of urine)

60+:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Pyrexia (fever)
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Inflammation
  5. Rash pruritic (redness with itching)
  6. Renal failure acute (rapid kidney dysfunction)
  7. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  8. Acute respiratory failure
  9. Blood urea increased
  10. Breath sounds

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 35.29%
  2. Fever: 5 people, 29.41%
  3. Bacterial Infection: 3 people, 17.65%
  4. Sedation: 3 people, 17.65%
  5. Upper Respiratory Tract Inflammation: 3 people, 17.65%
  6. Brain Abscess: 2 people, 11.76%
  7. Urinary Tract Infection: 2 people, 11.76%
  8. Intervertebral Discitis (infection in the intervertebral disc space): 2 people, 11.76%
  9. Pyogenic Liver Abscess (liver abscess caused by bacteria): 2 people, 11.76%
  10. Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Voltaren and Claforan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Voltaren and Claforan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Voltaren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Claforan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Voltaren and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Claforan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac sodium and cefotaxime sodium (the active ingredients of Voltaren and Claforan, respectively), and Voltaren and Claforan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: